Otsuka et al. reported that the tenascin-C-derived peptide TNIIIA2 combined with RA reduced neuroblastoma N-Myc protein levels, promoted differentiation, and inhibited tumor growth in a mouse model (Otsuka et al., 2019). Here, MYCN is linked to neuroblastoma.